4. INTANGIBLE ASSETS
|6 Months Ended|
Jun. 30, 2019
|Goodwill and Intangible Assets Disclosure [Abstract]|
|4. INTANGIBLE ASSETS||
Intangible assets at June 30, 2019 and December 31, 2018 consist of the following:
All of the Company’s intangible assets were acquired in the Biotest Transaction. Amortization expense related to these intangible assets for the six months ended June 30, 2019 and 2018 was $0.4 million. Estimated aggregate future aggregate amortization expense for the next five years is expected to be as follows:
No definition available.
The entire disclosure for all or part of the information related to intangible assets.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef